The brugada syndrome

Current Cardiology Reports

Volumn 2, Issue 6, 2000, Pages 507-514

  Brugada, Pedro ^a   Brugada, Ramon ^b   Brugada, Josep ^c  

^a OLV HOSPITAL   (Belgium)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CARDIOVERSION; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; FEMALE; HEART BUNDLE BRANCH BLOCK; HEART VENTRICLE TACHYCARDIA; HUMAN; INSTRUMENTATION; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; REVIEW; SUDDEN DEATH; SURVIVAL; SYNDROME;

ANTI-ARRHYTHMIA AGENTS; BUNDLE-BRANCH BLOCK; COMBINED MODALITY THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; PROGNOSIS; SURVIVAL ANALYSIS; SYNDROME; TACHYCARDIA, VENTRICULAR;

EID: 0034320247     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-000-0035-0     Document Type: Article

References (83)

1. Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992, 20:1391-1396.
2. Bjerregaard P, Gussak I, Kotar SL, et al.: Recurrent syncope in a patient with prominent J wave. Am Heart J 1994, 127:1426-1430.
3. Brugada P, Geelen P: Some electrocardiographic patterns predicting sudden cardiac death that every doctor should recognize. Acta Cardiol 1997, 52:473-484.
4. Bjerregaard P, Gussak I, Antzelevitch C: The enigmatic manifestation of Brugada syndrome. J Cardiovasc Electrophysiol 1998, 9:109-110.
5. Matduo K, Shimizu W, Kurita T, et al.: Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1998, 9:508-512.
6. Prieto-Solis JA, Martin-Duran A: Multiples cambios en la morfologia del segmento ST en un paciente con sindrome de Brugada. Rev Esp Cardiol 2000, 53:136-138.
7. Brugada P. Brugada syndrome: an electrocardiographic diagnosis not to be missed. Heart 2000, 84:1-3.
8. Miyazaki T, Mitamura H, Miyoshi S, et al.: Autonomic and antiarrhythmic modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996, 27:1061-1070.
9. Nakazato Y, Shimada K, Nakazato K, et al.: Abnormal ST elevation during oral pilsicainide treatment. Ther Res 1997, 18:357-362.
10. Nakazato Y, Nakata Y, Yasuda M, et al.: Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias. Jpn Heart J 1997, 38:379-385.
11. Kasanuki H, Ohnishi S, Ohtuka M, et al.: Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997, 95:2277-2285.
12. Goethals P, Debruyne P, Saffarian M: Drug-induced Brugada syndrome. Acta Cardiol 1998, 53:157-160.
13. Nakamura W, Segawa K, Ito H, et al.: Class Ic antiarrhythmic drugs, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia. J Cardiovasc Electrophysiol 1998, 9:855-858.
14. Krishnan S, Josephson M: ST segment elevation induced by class Ic antiarrhythmic agents: underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia. J Cardiovasc Electrophysiol 1998, 9:1167-1172.
15. Eckardt L, Kirchhof P, Johna R, et al.: Transient local changes in right ventricular monophasic action potentials due to ajmaline in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1999, 10:1010-1015.
16. Fujiki A, Usui M, Nagasawa H, et al.: ST segment elevation in the right precordial leads induced with class Ic antiarrhythmic drugs: Insight into the mechanism of Brugada syndrome. J Cardiovasc Electrophysiol 1999, 10:214-218.
17. Roden D, Wilde A: Drug-induced J point elevation: a marker for genetic risk of sudden death or ECG curiosity? J Cardiovasc Electrophysiol 1999, 10:219-223.
18. Brugada R, Brugada J, Antzelevitch A, et al.: Sodium channel blockers identify risk for sudden death in patients with ST segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000, 101:510-515.
19. Matana A, Goldner V, Stanic K, et al.: Unmasking effect of propafenone on the concealed form of the Brugada phenomenon. PACE 2000, 23:416-418.
20. Pinar E, G-Alberoal A, Martinez J, et al.: Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome. PACE 2000, 23:407-409.
21. Miyanuma H, Sakurai M, Odaka H: Two cases of idiopathic ventricular fibrillation with interesting electrocardiographic findings. Kokyu to Junkan 1993, 41:287-291.
22. Brembilla-Perrot B, Beurrier D, Jacquemin L, et al.: Incomplete bundle branch block and ST-segment elevation: syndrome associated with sustained monomorphic ventricular tachycardia in patients with apparently normal heart. Clin Cardiol 1997, 20:407-410.
23. Brugada J, Brugada R, Brugada P: Right bundle branch block and ST segment elevation in leads V1-V3: A marker for sudden death in patients with no demonstrable structural heart disease. Circulation 1998, 97:457-460.
24. Gussak I, Antzelevitch C, Bjerregaard P, et al.: The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999, 33:5-15.
25. Brugada J, Brugada P, Brugada R: The syndrome of right bundle branch block, ST segment elevation in V1 to V3 and sudden death - the Brugada syndrome. Europace 1999, 1:156-166.
26. Grace AA: Brugada syndrome. Lancet 1999, 354:445-446.
27. Brugada P, Brugada J, Brugada R: The Brugada syndrome. Cardiac Electrophysiol Rev 1999, 3:42-44.
28. Itoh E, Suzuki K, Tanabe Y: A case of vasospastic angina presenting Brugada-type ECG abnormalities. Jpn Circ J 1999, 63:493-495.
29. Tarin N, Farre J, Rubio JM, et al.: Brugada-like electrocardiographic pattern in a patient with a mediastinal tumor. PACE 1999, 22:1264-1266.
30. Tomaszewski W: Changements electrocardiographiques observes chez un homme mort de froid. Arch Mal Coeur 1938, 31:525-528.
31. Anguera I, Valls V: Giant J waves in hypothermia. Circulation 2000, 101:1627-1628.
32. Nacarella F: Malignant ventricular arrhythmias in patients with a right bundle branch block and persistent ST segment elevation in V1-V3: a probable arrhythmogenic cardiomyopathy of the right ventricle. G Ital Cardiol 1993, 23:1219-1222.
33. Corrado D, Nava A, Buja G, et al.: Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996, 27:443-448.
34. Brugada J, Brugada P: Further characterisation of the syndrome of right bundle branch block, ST segment elevation and sudden cardiac death. J Cardiovasc Electrophysiol 1997, 8:325-331.
35. Brugada P, Brugada J, Brugada R: "Brugada syndrome" : a structural cardiomyopathy or a functional electrical disease? In Cardiac Arrhythmias. Edited by Ravieli F. Venice: Springer-Verlag; 1997.
36. Fontaine G, Aouate P, Fontaliran F: Arrhythmogenic right ventricular dysplasia, torsade de pointes and sudden death. New concepts. Ann Cardiol Angeiol 1997, 46:531-538.
37. Lorga Filho A, Brugada P: Right bundle branch block, ST segment elevation from V1 to V3 and sudden death. What we know about this peculiar and clinical electrocardiographic syndrome. Arq Bras Cardiol 1997, 68:205-208.
38. Lorga Filho A, Prino J, Brugada J, Brugada P: Right bundle branch block, the elevation of the ST segment in V1 to V3 and sudden death: the diagnostic and therapeutic approach. Rev Port Cardiol 1997, 16:443-447.
39. Tada HT, Aihara N, Ohe T, et al.: Arrhythmogenic right ventricular cardiomyopathy underlies syndrome of right bundle branch block, ST-segment elevation, and sudden death. Am J Cardiol 1998, 81:519-522.
40. Zipes D, Wellens HJJ: Sudden cardiac death. Circulation 1998, 98:2334-2351.
41. Eriksson P, Hansson P, Eriksson H, Dellborg M: Bundle-branch block in a general male population. Circulation 1998, 98:2494-2500.
42. Corrado D, Buja G, Baso C, et al.: What is the Brugada syndrome? Cardiology Rev 1999, 7:191-195.
43. Izumi T, Ajiki K, Nozaki A, et al.: Right ventricular cardiomyopathy showing right bundle branch block and right precordial ST segment elevation. Intern Med 2000, 39:28-33.
44. Brugada J, Brugada P, Brugada R: El sindrome de Brugada y las cardiopatias derechas como causa de muerte subita. Rev Esp Cardiol 2000, 53:272-285.
45. Yoshioka N, Tsuchihashi K, Yuda S, et al.: Electrocardiographic and echocardiographic abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy and their pedigrees. Am J Cardiol 2000, 85:885-889.
46. Izumi T, Ajiki K, Nozaki A, et al.: Right ventricular cardiomyopathy showing right bundle branch block and right precordial ST segment elevation. Intern Med 2000, 39:28-33.
47. Chen Q, Kirsch GE, Zhang D, et al.: Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 1998, 392:293-296.
48. Bezzina C, Veldkamp MW, van den Berg MP, et al.: A single Na+ channel mutation causing both long-QT and Brugada syndrome. Circ Res 1999, 85:1206-1213.
49. Rook MB, Alshinawi CB, Groenewegen WA, et al.: Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res 1999, 44:507-517.
50. Coonar A, Protonotarios N, Tsatsopoulou A, et al.: Gene for arrhythmogeneic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998, 97:2049-2058.
51. Stephan E, Chedid R, Loiselet J, Bouvagnet P: Génétique clinique et moléculaire d' un bloc de branche familial lié au chromosome 19. Arch Mal Coeur 1998, 91:1465-1474.
52. Barinaga M: Tracking down mutations that can stop the heart. Science 1998, 281:32-34.
53. Probst V, Hoorntje TM, Hulsbeek M, et al.: Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999, 23:20-21.
54. Priori S, Barhanin J, Hauer R, et al.: Genetic and molecular basis of cardiac arrhythmias: impact on clinical management. Parts I and II. Circulation 1999, 99:518-528.
55. Litovsky SH, Antzelevitch C: Rate dependence of action potential duration and refractoriness in canine ventricular endocardium differs from that of epicardium: Role of the transient outward current. J Am Coll Cardiol 1989, 14:1053-1066.
56. Litovsky SH, Antzelevitch C: Differences in the electrophysiologic response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. Circ Res 1990, 67:615-627.
57. Yan G-X, Antzelevitch C: Cellular basis for the electrocardiographic J wave. Circulation 1996, 93:372-379.
58. Krishnan SC, Antzelevitch C: Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 re-entry? Circulation 1992, 87:562-572.
59. Matsuo K, Shimizu W, Kurita T, et al.: Increased dispersion of repolarisation time determined by monophasic action potentials in two patients with familial idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 1998, 9:74-83.
60. Antzelevitch A: The Brugada syndrome. J Cardiovasc Electrophysiol 1998, 9:513-516.
61. Okazaki O, Yamauchi Y, Kashida M, et al.: Possible mechanism of ECG features in patients with idiopathic ventricular fibrillation studied by heart model and computer simulation. J Electrocardiol 1998, 30:98-104.
62. Yan GX, Antzelevitch C: Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 1999, 100:1660-1666.
63. Antzelevitch C, Brugada P, Brugada J, et al.: The Brugada syndrome. Armonk, NY; Futura Publishing Inc: 1999.
64. Dumaine R, Towbin J, Brugada P, et al.: Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 1999, 85:803-809.
65. Balser JR: Sodium "channelopathies" and sudden death: must you be so sensitive? Circ Res 1999, 85:872-874.
66. Antzelevitch C, Yan GX, Shimizu W: Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. J Electrocardiol 1999, 32:158-165.
67. Makita N, Shirai N, Wang DW, et al.: Cardiac Na+ channel dysfunction in Brugada syndrome is aggravated by B1 subunit. Circulation 2000, 101:54-60.
68. Baroudi G, Carbonneau E, Pouliot V, Chahine M: SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cells. FEBS Lett 2000, 467:12-16.
69. Deschenes I, Batoudi G, Berthet M, et al.: Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1432G) syndromes. Cardiovasc Res 2000, 46:55-65.
70. Shimizu W, Matsuo K, Takagi M: Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 2000, 11:396-404.
71. Gonzalez Rebollo JM, Hernandez Madrid A, Garcia A, et al.: Recurrent ventricular fibrillation during a febrile illness in a patient with the Brugada syndrome. Rev Esp Cardiol 2000, 53:755-757.
72. Sao N, Akasaka K, Kawashima E, et al.: A case of idiopathic ventricular fibrillation with possible mechanism of autonomic dysfunction. Jpn J Electrocardiol 1994, 14:206-217.
73. Matsuo K, Kurita T, Inagaki M, et al.: The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 1999, 20:465-470.
74. Leenhardt L, Glaser E, Burguera M, et al.: Short-coupled variant of torsade de pointes: A new electrocardiographic entity in the spectrum of idiopathic ventricular arrhythmias. Circulation 1994, 89:206-215.
75. Fisher JD, Krikler D, Hallidie-Smith KA: Familial polymorphic ventricular arrhythmias. J Am Coll Cardiol 1999, 34:2015-2022.
76. Swan H, Piippo K, Viitsalo M, et al.: Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999, 34:2035-2042.
77. Viskin S, Fish R, Eldar M, et al.: Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls. Heart 2000, 84:31-36.
78. Nademanee KK, Veerakul G, Nimmannit S, et al.: Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997, 96:2595-2600.
79. Hermida J, Lemoine J, Aoun FB, et al.: Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol 2000, 86:91-94.
80. Priori S, Napolitano C, Giordano U, et al.: Brugada syndrome and sudden cardiac death in children. The Lancet 2000, 355:808-809.
81. Benhorin J, Taub R, Goldmit M, et al.: Effects of flecainide in patients with new SCN5A mutation. Mutation-specific therapy for long QT syndrome? Circulation 2000, 101:1698-1706.
82. Brugada P, Brugada R, Brugada J: Sudden death in patients and relatives with the syndrome of right bundle branch block, ST segment elevation in the precordial leads V1 to V3 and sudden death. Eur Heart J 2000, 21:321-326.
83. Holtzman NA, Marteau TM: Will genetics revolutionize medicine ? N Engl J Med 2000, 343:141-144.